145
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease

, , , , , , & show all
Pages 2847-2854 | Published online: 03 Nov 2015

References

  • StrongMJLomen-HoerthCCaselliRJBigioEHYangWCognitive impairment, frontotemporal dementia, and the motor neuron diseasesAnn Neurol200354Suppl 5S20S2312833364
  • MehtaPAntaoVKayeWPrevalence of amyotrophic lateral sclerosis – United States, 2010–2011MMWR Surveil Summ201463Suppl 7114
  • ChancellorAMWarlowCPAdult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950J Neurol Neurosurg Psychiatry19925512110611151479386
  • ChancellorAMWarlowCPCarstairsVEltonRASwinglerRJAffluence, age, and motor neuron diseaseJ Epidemiol Community Health19924621721731583438
  • RingelSPMurphyJRAldersonMKThe natural history of amyotrophic lateral sclerosisNeurology1993437131613228327132
  • BlascoHMavelSCorciaPGordonPHThe glutamate hypothesis in ALS: pathophysiology and drug developmentCurr Med Chem201421313551357525245510
  • ScarrottJMHerranz-MartinSAlrafiahARShawPJAzzouzMCurrent developments in gene therapy for amyotrophic lateral sclerosisExpert Opin Biol Ther2015113
  • HootenKGBeersDRZhaoWAppelSHProtective and toxic neuroinflammation in amyotrophic lateral sclerosisNeurotherapeutics201512236437525567201
  • BucchiaMRamirezAParenteVTherapeutic development in amyotrophic lateral sclerosisClin Ther201537366868025666449
  • GrafMEckerDHorowskiRHigh dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind studyJ Neural Transm2005112564966015517433
  • YacilaGSariYPotential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosisCurr Med Chem201421313583359324934355
  • LeeCTChiuYWWangKCRiluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in TaiwanJ Epidemiol2013231354023117224
  • Jelsone-SwainLPersadCVotrubaKLThe relationship between depressive symptoms, disease state, and cognition in amyotrophic lateral sclerosisFront Psychol2012354223411492
  • DevenneyEVucicSHodgesJRKiernanMCMotor neuron disease-frontotemporal dementia: a clinical continuumExp Rev Neurother2015155509522
  • AbeKFujimuraHToyookaKSakodaSYorifujiSYanagiharaTCognitive function in amyotrophic lateral sclerosisJ Neurol Sci19971481951009125395
  • MitsuyamaYDementia with motor neuron diseaseNeuropathology200020SupplS79S8111037194
  • SnowdenJSNearyDMannDMFrontotemporal dementiaBr J Psychiatry200218014014311823324
  • StrongMJGraceGMFreedmanMConsensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosisAmyotroph Lateral Scler200910313114619462523
  • GirardiAMacphersonSEAbrahamsSDeficits in emotional and social cognition in amyotrophic lateral sclerosisNeuropsychology2011251536520919762
  • VignolaAGuzzoACalvoAAnxiety undermines quality of life in ALS patients and caregiversEur J Neurol200815111231123618803649
  • TramontiFBongioanniPDi BernardoCDavittiSRossiBQuality of life of patients with amyotrophic lateral sclerosisPsychol Health Med201217562162822313252
  • DiamondBJJohnsonSKKaufmanMGravesLRelationships between information processing, depression, fatigue and cognition in multiple sclerosisArch Clin Neuropsychol200823218919918053682
  • SassoonSARosenbloomMJFamaRSullivanEVPfefferbaumASelective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidityPsychiatry Res2012199210211022648011
  • SimmonsZBremerBARobbinsRAWalshSMFischerSQuality of life in ALS depends on factors other than strength and physical functionNeurology200055338839210932273
  • RabkinJGAlbertSMDel BeneMLPrevalence of depressive disorders and change over time in late-stage ALSNeurology2005651626716009886
  • McLeodJEClarkeDMA review of psychosocial aspects of motor neurone diseaseJ Neurol Sci20072581–241017445834
  • McDonaldERWiedenfeldSAHillelACarpenterCLWalterRASurvival in amyotrophic lateral sclerosis. The role of psychological factorsArch Neurol199451117238274106
  • AtassiNCookAPinedaCMYerramilli-RaoPPulleyDCudkowiczMDepression in amyotrophic lateral sclerosisAmyotroph Lateral Scler201112210911221091399
  • OhHSinMKScheppKGChoi-KwonSDepressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South KoreaRehabil Nurs201237313614422549631
  • BrooksBRMillerRGSwashMMunsatTLWorld Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotroph Lateral Scler Other Motor Neuron Disord20001529329911464847
  • IkemotoAHiranoAAkiguchiINeuropathology of amyotrophic lateral sclerosis with extra-motor system degeneration: characteristics and differences in the molecular pathology between ALS with dementia and Guamanian ALSAmyotroph Lateral Scler Other Motor Neuron Disord2000129710411467056
  • MolloyDWStandishTIA guide to the standardized Mini-Mental State ExaminationInt Psychogeriatr19979Suppl 18794 discussion 143–1509447431
  • The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I–II Study GroupArch Neurol19965321411478639063
  • ZungWWA rating instrument for anxiety disordersPsychosomatics19711263713795172928
  • ZungWWA Self-Rating Depression ScaleArch Gen Psychiatry196512637014221692
  • StrongMJGraceGMOrangeJBLeeperHACognition, language, and speech in amyotrophic lateral sclerosis: a reviewJ Clin Exp Neuropsychol19961822913038780963
  • GallassiRMontagnaPCiardulliCLorussoSMussutoVStracciariACognitive impairment in motor neuron diseaseActa Neurol Scand19857164804844024859
  • KiernanMCIdentification of cognitive deficits in amyotrophic lateral sclerosisClin Neurophysiol2009120464564619286420
  • SeemanMVPsychopathology in women and men: focus on female hormonesAm J Psychiatry199715412164116479396940
  • WicksPAbrahamsSMasiDHejda-FordeSLeighPNGoldsteinLHPrevalence of depression in a 12-month consecutive sample of patients with ALSEur J Neurol2007149993100117718691
  • KurtANijboerFMatuzTKublerADepression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and managementCNS Drugs200721427929117381183
  • MillecampsSBoilleeSLe BerIPhenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genesJ Med Genet201249425826322499346
  • Van den BergJPKalmijnSLindemanEMultidisciplinary ALS care improves quality of life in patients with ALSNeurology20056581264126716247055